Introduction {#Sec1}
============

A concentric left ventricular (LV) structure is the result of remodeling that occurs with LV wall thickening relative to the LV cavity to compensate for pressure overload \[[@CR1], [@CR2]\]. A concentric LV structure is a risk factor for cardiovascular events in hypertensive patients \[[@CR3], [@CR4]\]. Furthermore, we previously reported that a concentric LV structure evaluated by transthoracic echocardiography (TTE) was associated with poor survival in patients with acute decompensated heart failure (ADHF) \[[@CR5]\].

Relative wall thickness (RWT) is an index of LV concentricity. RWT is the ratio of LV wall thickness to the LV internal dimension at end diastole (LVDd) \[[@CR6]\]. LV wall thickness, which can be measured in a parasternal long-axis view by TTE, is represented by the Interventricular septum wall thickness (IVSth) and the posterior wall thickness (PWth) \[[@CR6]\]. Therefore, there are three methods to calculate the RWT: RWT~PW~ = 2 × PWth/LVDd; RWT~IVS + PW~ = (IVSth + PWth) LVDd; and RWT~IVS~ = 2 × IVSth/LVDd. The American Society of Echocardiography (ASE) recommends RWT~PW~ for calculating RWT \[[@CR6]\]. However, some studies found that RWT~IVS + PW~ had clinical significance \[[@CR7], [@CR8]\]. The difference in clinical significance among the three methods of measuring RWT is unclear.

To compare the clinical significance of RWT~PW~, RWT~IVS + PW~, and RWT~IVS~, the prognostic values of the RWTs were examined and compared in patients with ADHF.

Materials and methods {#Sec2}
=====================

Participants {#Sec3}
------------

This was a single-center, retrospective, observational study conducted at a Japanese community hospital. In total, 426 consecutive patients admitted due to ADHF through the clinic or emergency room were recruited between June 2014 and April 2016 and followed-up from June 2014 to September 2016. A total of 41 patients were excluded for any of the following reasons: no TTE on admission (*n* = 35); and RWT not measured (*n* = 6). Finally, 385 patients were eligible for the analysis (Fig. [1](#Fig1){ref-type="fig"}). We previously documented the enrolled patients in detail \[[@CR5]\]. Fig. 1Flowchart of enrollment. RWT, relative wall thickness; TTE, transthoracic echocardiography

The present study followed the tenets of the Declaration of Helsinki and the Ethical Guidelines for Medical and Health Research Involving Human Subjects proposed by the Ministry of Health and Welfare in Japan. The institutional ethics committee at Tomishiro Central Hospital approved the present study and waived informed consent because of the observational nature of the study.

Transthoracic echocardiography {#Sec4}
------------------------------

Comprehensive TTE (Vivid 7 ultrasound system, GE Vingmed Ultrasound, Horten, Norway) was performed during hospital admission by four medical technicians who had at least 5 years of experience performing TTE. Their measurements followed established and standardized methods recommended by the ASE and the European Society of Cardiology. At least two attending cardiologists certified by the Japanese Circulation Society and an experienced sonographer reviewed the echocardiography reports immediately after comprehensive TTE. LV geometry, including PWth, IVSth, and LVDd, was measured in M-mode in a parasternal long-axis view \[[@CR6]\]. All measurements were performed from the leading edge to the leading edge \[[@CR6]\]. RWTs were calculated by the three measurement methods and defined as follows: RWT~PW~ = 2 × PWth/LVDd; RWT~IVS + PW~ = (IVSth + PWth)/LVDd; and RWT~IVS~ = 2 × IVSth/LVDd. The patients were divided into two groups based on the median RWT~PW~ (low- and high-RWT~PW~), median RWT~IVS + PW~ (low- and high-RWT~IVS + PW~), or median RWT~IVS~ (low- and high-RWT~IVS~).

Left ventricular ejection fraction (LVEF) was assessed using the biplane Simpson's method \[[@CR6]\]. Heart failure with preserved ejection fraction (HFpEF) was defined as an ejection fraction ≥50% \[[@CR9]\]. LV mass was computed by the Cube formula \[[@CR6]\]. LV end-diastolic volume (LVEDVI) was estimated by the Teichholz equation \[[@CR10]\]. Peak transmitral early diastolic wave (E wave) velocity, atrial contraction wave (A wave) velocity, and deceleration time (DCT) were measured by the pulse wave Doppler signals of the mitral inflow in the apical four-chamber view \[[@CR11]\]. Valvular diseases were evaluated using a semiquantitative 4-grade scale (none, mild, moderate, and severe**)** \[[@CR12]\].

Data collection {#Sec5}
---------------

Cardiologists followed the patients at Tomishiro Central Hospital Clinic every 1--3 months after hospital discharge. Medical clerks confirmed the patients' condition if the patients canceled the appointment.

Patients' medical charts were reviewed to collect their demographic characteristics and clinical data, including medications, laboratory tests, and hemodynamic data on hospital admission. The primary outcome was all-cause death. Death was confirmed by the medical chart, telephone call with a patient's family, or obituary in local newspapers.

Statistical analysis {#Sec6}
--------------------

Continuous variables with normal and skewed distributions are presented as means (SD) and medians \[25th, 75th percentiles\], respectively. Categorical variables are presented as numbers with a percentage.

In two-group comparisons, Student's *t*-test and the Mann-Whitney U test were used to compare normally distributed and non-normally distributed continuous variables, respectively. Fisher's exact test was used for categorical variables.

Survival analysis {#Sec7}
-----------------

During follow-up (235 \[92, 425\] days), 95/385 (25%) patients died. Survival analysis for all-cause death was performed. Kaplan-Meier curves were stratified by RWT~PW~, RWT~IVS + PW~, and RWT~IVS~. The log-rank test was used to compare survival curves. High-RWT~PW~, high-RWT~IVS + PW~, and high-RWT~IVS~ were examined by univariate Cox proportional hazard models and a Cox proportional hazard model adjusted by the Get With The Guideline score (GWTG) \[[@CR13], [@CR14]\], an established risk score for mortality in patients with acute heart failure, to obtain hazard ratios (HRs) and 95% confidence intervals (95% CIs).

Logistic regression model for 90-day mortality {#Sec8}
----------------------------------------------

A total of 48 patients who were lost to follow-up were excluded to evaluate the risk of 90-day mortality. Logistic regression models were used to obtain the odds ratios (ORs) of 90-day mortality and 95% CIs. High-RWT~PW~, high-RWT~IVS + PW~, and high-RWT~IVS~ were examined in univariate logistic regression models and a logistic regression model adjusted by GWTG.

Receiver operating curves for 90-day mortality {#Sec9}
----------------------------------------------

Receiver operating curves for 90-day mortality were drawn using RWT~PW~, RWT~IVS + PW~, and RWT~IVS~ to obtain c-statistics, and the best RWT cut-off values were determined by the maximum Youden index \[[@CR15]\].

Sensitivity analysis of the survival analysis by stratified RWTs by the best cut-off {#Sec10}
------------------------------------------------------------------------------------

To confirm the consistency of the survival analysis, the participants were divided based on the best RWT cut-off value derived from the Youden index.

Survival analysis was performed to compare low and high-RWTs. High-RWT~PW~, high-RWT~IVS + PW~, and high-RWT~IVS~ were also examined with univariate and adjusted proportional Cox hazard models.

Relationships between RWTs and clinical characteristics {#Sec11}
-------------------------------------------------------

Spearman's correlation coefficient (ρ) was used to identify significant associations between RWTs and clinical characteristics: age, the natural logarithm of brain natriuretic peptide (logBNP), LVEF, LVEDV, and systolic blood pressure (SBP).

Reliability of measurement of PWth and IVSth {#Sec12}
--------------------------------------------

The reliabilities of the TTE measurements of PWth, IVSth, and LVDd were examined in 25 patients whose TTE image quality was good, and all of the patients underwent TTE performed by the same one of four medical technicians. The medical technician and two other examiners re-measured PWth and IVSth in the TTE image stored in the local server on hospital admission, using an off-line image analysis system (Nahri Aqua, Mehergen Group, Fukuoka, Japan). Comparing every two examiners' measurements, Bland-Altman plots were used to assess the agreement between the measurement by the same examiner and different examiners \[[@CR16]\]. The inter-class coefficient (ICC) was computed to assess agreement \[[@CR17]\].

The reliabilities of RWT~PW~, RWT~IVS + PW~, and RWT~IVS~ were also examined. RWTs were computed using PWth, IVSth, and LVDd measured by three examiners. Bland-Altman plots were drawn, and the ICC and *P* values were calculated.

Software {#Sec13}
--------

The statistical software used was R 3.4.3 (R Foundation for Statistical Computing, Vienna, Australia). All reported *P* values are two-tailed, and a *P* value \< 0.05 was considered significant.

Results {#Sec14}
=======

Participants {#Sec15}
------------

The participants' median age was 81 years, and there were 181/385 (47%) men in the overall population. Comparing low- and high-RWT~PW~, high-RWT~PW~ had more elderly patients and more females, whereas in comparisons between low- and high-RWT~IVS + PW~ and between low- and high-RWT~IVS~, there were no significant differences in baseline characteristics (Table [1](#Tab1){ref-type="table"}). Table 1Demographic data and echocardiographic parametersOverallRWT~PW~^b^RWT~IVS + PW~^b^RWT~IVS~^b^LowHigh*P* valueLowHigh*P* valueLowHigh*P* value*n* = 385*n* = 193*n* = 192*n* = 193*n* = 192*n* = 193*n* = 192Age, y81 \[70, 88\]80 \[68, 87\]83 \[73, 89\]0.02180 \[69, 87\]83 \[73, 89\]0.06780 \[69, 87\]83 \[73, 88\]0.082Mele, n (%)181/385 (47)104/193 (54)77/192 (40)0.00899/193 (51)82/192 (43)0.198/193 (51)83/192 (43)0.15Height, cm154 ± 10156 ± 9.7153 ± 9.90.002155 ± 10153 ± 100.048155 ± 10153 ± 100.15Body weight., kg60 ± 1660 ± 1560 ± 170.9561 ± 1559 ± 170.4560 ± 1659 ± 160.59Body mass index, kg/m^2^22.8 ± 4.622.6 ± 4.523.0 ± 4.80.4222.8 ± 4.622.8 ± 4.70.9922.9 ± 4.722.8 ± 4.60.87Body surface area, m^2^1.51 ± 0.221.53 ± 0.221.49 ± 0.230.111.53 ± 0.221.50 ± 0.230.21.52 ± 0.221.50 ± 0.220.3Get With The Guideline score38 ± 738 ± 638 ± 80.9938 ± 738 ± 80.5538 ± 738 ± 80.86Hospital stay, days13 \[8, 20\]13 \[8, 21\]12 \[8, 19\]0.5513 \[8, 21\]12 \[8, 19\]0.3513 \[8, 20\]12 \[8, 19\]0.76Past medical history, n (%) Hypertension187/385 (49)92/193 (48)95/192 (50)0.7692/193 (48)95/192 (50)0.7693/193 (48)94/192 (49)0.92 Diabetes mellitus132/385 (34)68/193 (35)64/192 (33)0.7575/193 (39)57/192 (30)0.06880/193 (42)52/192 (27)0.004 Chronic obstructive pulmonary disease18/385 (4.7)7/193 (3.6)11/192 (5.7)0.357/193 (3.6)11/192 (5.7)0.358/193 (4.1)10/192 (5.2)0.64 Old myocardial infarction62/385 (16)37/193 (19)25/192 (13)0.1335/193 (18)27/192 (14)0.3334/193 (18)28/192 (15)0.49Echocardiographic parameters RWT~PW~^a^0.36 ± 0.120.28 ± 0.050.45 ± 0.12\<  0.0010.28 ± 0.050.44 ± 0.12\<  0.0010.30 ± 0.070.43 ± 0.13\<  0.001 RWT~IVS + PW~^a^0.37 ± 0.130.29 ± 0.060.45 ± 0.12\<  0.0010.28 ± 0.050.46 ± 0.12\<  0.0010.29 ± 0.060.46 ± 0.12\<  0.001 RWT~IVS~^a^0.38 ± 0.140.30 ± 0.090.46 ± 0.15\<  0.0010.29 ± 0.060.48 ± 0.14\<  0.0010.28 ± 0.060.48 ± 0.13\<  0.001 IVSth, mm9.4 ± 2.48.5 ± 2.010.4 ± 2.4\<  0.0018.1 ± 1.810.7 ± 2.2\<  0.0017.9 ± 1.511.0 ± 2.1\<  0.001 PWth, mm9.0 ± 2.17.8 ± 1.310.3 ± 2.0\<  0.0018.1 ± 1.410 ± 2.2\<  0.0018.3 ± 1.69.8 ± 2.3\<  0.001 LVDd, mm52 ± 9.757.1 ± 8.846.8 ± 7.8\<  0.00157.7 ± 8.246.2 ± 7.6\<  0.00157 ± 8.846.8 ± 7.8\<  0.001 LVEF, (%)47 ± 1741 ± 1651 ± 16\<  0.00139 ± 1652 ± 16\<  0.00140 ± 1651 ± 16\<  0.001 HFpEF (LVEF ≥ 50%), n (%)157/383 (41)56/193 (29)101/190 (53)\<  0.00147/193 (24)110/190 (58)\<  0.00150/193 (26)107/190 (56)\<  0.001 LVM, g168 \[131, 211\]173 \[135, 211\]164 \[132, 208\]0.51174 \[138, 211\]164 \[123, 208\]0.18170 \[135, 207\]166 \[130, 212\]0.9 LVEDV, mL130 \[92, 167\]160 \[130, 194\]102 \[79, 126\]\<  0.001160 \[130, 194\]97 \[74, 124\]\<  0.001160 \[124, 194\]102 \[79, 130\]\<  0.001 LVM/LVEDV1.43 ± 0.561.10 ± 0.231.75 ± 0.61\<  0.0011.08 ± 0.201.77 ± 0.59\<  0.0011.09 ± 0.211.76 ± 0.6\<  0.001 E wave, cm/sec97 ± 2997 ± 3097 ± 280.9495 ± 2899 ± 290.3798 ± 3096 ± 280.58 A wave, cm/sec76 ± 3270 ± 2982 ± 340.01173 ± 2979 ± 340.1374 ± 3077 ± 330.57 E/A1.21 \[0.84, 1.83\]1.29 \[0.89, 2.04\]1.15 \[0.82, 1.68\]0.181.21 \[0.84, 1.84\]1.21 \[0.86, 1.81\]0.811.22 \[0.84, 1.83\]1.17 \[0.85, 1.83\]0.6 Deceleration time, ms150 \[123, 195\]150 \[121, 196\]150 \[128, 192\]0.49149 \[119, 185\]150 \[129, 200\]0.043147 \[118, 181\]152 \[129, 201\]0.013 Aortic valve stenosis, n (%)29/385 (7.5)7/193 (3.6)22/192 (12)0.0048/193 (4.1)21/192 (11)0.0128/193 (4.1)21/192 (11)0.012 Aortic valve regurgitation, n (%)24/385 (6.2)14/193 (7.3)10/192 (5.2)0.5314/193 (7.3)10/192 (5.2)0.5311/193 (5.7)13/192 (6.8)0.68 Mitral valve regurgitation, n (%)59/385 (15)39/193 (20)20/192 (10)0.0140/193 (21)19/192 (9.9)0.00441/193 (21)18/192 (9.4)0.002Laboratory data Blood urea nitrogen, mg/dL24 \[17, 35\]24 \[17, 34\]24 \[17, 36\]0.7724 \[17, 35\]24 \[17, 35\]0.6724 \[17, 36\]23 \[17, 35\]0.76 Creatinine, mg/dL1.14 \[0.81, 1.52\]1.15 \[0.83, 1.54\]1.09 \[0.79, 1.51\]0.311.18 \[0.83, 1.56\]1.09 \[0.79, 1.50\]0.221.17 \[0.83, 1.55\]1.07 \[0.79, 1.50\]0.19 Hemoglobin, g/dL12.0 ± 2.412.0 ± 2.411.9 ± 2.40.8411.9 ± 2.412.0 ± 2.40.7811.9 ± 2.512 ± 2.30.68 Brain natriuretic peptide, pg/mL666 \[427, 1266\]737 \[449, 1376\]638 \[403, 1155\]0.056765 \[472, 1376\]636 \[401, 1092\]0.026683 \[437, 1349\]645 \[413, 1190\]0.28Medication, n (%) ACE-I and/or ARB124/285 (32)71/193 (37)53/192 (28)0.06967/193 (35)57/192 (30)0.3466/193 (34)58/192 (30)0.47 Beta blocker153/385 (40)78/193 (40)75/192 (39)0.06975/193 (39)78/192 (41)0.874/193 (38)79/192 (41)0.65Hemodynamic data Systolic blood pressure, mmHg132 ± 26128 ± 24135 ± 290.006131 ± 24133 ± 290.35130 ± 24134 ± 290.13 Diastolic blood pressure, mmHg78 ± 2175 ± 1973 ± 170.00974 ± 1877 ± 210.1774 ± 1877 ± 210.1 Heart rate, bpm84 ± 2183 ± 2184 ± 210.8183 ± 1984 ± 220.6483 ± 1983 ± 220.78A wave, late mitral valve inflow velocity; *ACE-I* angiotensin converting enzyme inhibitor; *ARB* angiotensin receptor blocker; E wave, early mitral valve inflow velocity; *IVSth* interventricular septum thickness; *LVEDV* left ventricular end diastolic volume; *LVDd* left ventricular internal dimension at end-diastole; *LVEF* left ventricular ejection fraction; *LVM* left ventricular mass; *PWth* posterior wall thickness; *RWT* relative wall thickness^a^RWT was the ratio of left ventricular wall thickness to LVDd. Left ventricular wall thickness was measured at interventricular septum as IVSth and posterior wall as PWth. Three measurement methods to compute RWT were as follows; RWT~PW~ = 2 × PWth/LVDd, RWT~IVS\ +\ PW~ = (PWth + IVSth)/LVDd, and RWT~IVS~ = 2 × IVSth/LVDd^b^The patients were divided into two groups based on the median of RWT~PW~, RWT~IVS + PW~, and RWT~IVS~

Transthoracic echocardiography {#Sec16}
------------------------------

The mean RWT~PW~, RWT~IVS + PW~, and RWT~IVS~ values in the overall population were 0.36 ± 0.12, 0.37 ± 0.13, and 0.38 ± 0.14, respectively.

On comparing the three RWTs (low- vs. high- RWT~PW~, RWT~IVS + PW~, RWT~IVS~), high-RWTs had thicker IVSth and PWth, smaller LVDd, greater LVEF, smaller LV end-diastolic volume, high LVM/LVEDV, and less severe mitral regurgitation than low-RWTs (Table [1](#Tab1){ref-type="table"}).

Survival analysis {#Sec17}
-----------------

During follow-up (235 \[92, 425\] days), 95/385 (25%) patients died in the overall population.

Comparing low- and high-RWT~PW~, there was a significant difference in the incidence of all-cause death (low 36/193 (19%) vs. high-RWT~PW~ 59/192 (31%), *P* = 0.007). Kaplan-Meier curves showed that high-RWT~PW~ had worse survival than low-RWT~PW~ (*P* for log-rank test = 0.009; Fig. [2](#Fig2){ref-type="fig"}a). Fig. 2Kaplan-Meier Curves for all-cause death stratified by the RWTs. RWT, relative wall thickness. RWT~PW~ = 2 × PWth/LVDd, RWT~IVS + PW~ = (IVSth + PWth)/LVDd, and RWT~IVS~ = 2 × IVSth/LVDd. The patients were divided into two groups based on the median RWTs

Comparing low- and high-RWT~IVS + PW~, there was no significant difference in all-cause death (low 40/193 (21%) vs. high-RWT~PW~ 55/192 (29%), *P* = 0.077) or survival (*P* for log-rank test = 0.074; Fig. [2](#Fig2){ref-type="fig"}b).

In a comparison between low- and high-RWT~IVS~, there was no significant difference in all-cause death (low 42/193 (22%) vs. high-RWT~IVS~ 53/192 (28%), *P* incidence = 0.2) or survival (*P* for log-rank test = 0.19; Fig. [2](#Fig2){ref-type="fig"}c).

Cox proportional hazard models for all-cause death {#Sec18}
--------------------------------------------------

In the unadjusted and adjusted Cox proportional hazard models, high-RWT~PW~ was a significant risk factor for all-cause death (unadjusted Cox model, HR (95% CI), 1.72 (1.41--2.61), *P* = 0.01; adjusted Cox model, 1.95 (1.28--2.98), *P* = 0.02; Table [2](#Tab2){ref-type="table"}). Table 2Cox proportional hazard model for evaluate the risk of RWTs for all-cause mortalityCalculate method and factorUnadjustedAdjusted by GWTGEvent/casesHR95% CI*P* valueEvent/cases^a^HR95% CI*P* valueHigh- to low-RWT~PW~95/3851.721.14--2.610.0193/3801.951.28--2.980.002High- to low-RWT~IVS + PW~95/3851.450.96--2.170.07593/3801.531.01--2.320.045High- to low-RWT~IVS~95/3851.310.87--1.960.1993/3801.360.9--2.060.14*CI* confidence interval; *GWTG* Get With The Guideline score; *HR* hazard ratio; *RWT* relative wall thickness^a^5 cases were removed because of GWTG missing

High-RWT~IVS + PW~ was not a significant risk factor for all-cause death in the unadjusted Cox proportional model (unadjusted Cox model, HR, 1.45 (0.96--2.17), *P* = 0.075), but it was in the adjusted Cox proportional hazard model (adjusted Cox model, 1.53 (1.01--2.32), *P* = 0.045; Table [2](#Tab2){ref-type="table"}).

High-RWT~IVS~ was not a significant factor in either the unadjusted or the adjusted Cox proportional hazard model (Table [2](#Tab2){ref-type="table"}).

Logistic regression models for 90-day mortality {#Sec19}
-----------------------------------------------

The OR of high- to low-RWT~PW~ was significant (univariate, OR, 2.19, 95%CI, 1.15--2.19, *P* = 0.017; adjusted, OR, 2.26, 95%CI, 1.16--4.4, P = 0.017) on univariate analysis and the adjusted logistic regression model (Table [3](#Tab3){ref-type="table"}). In contrast, the OR of neither high to low-RWT~IVS + PW~ nor RWT~IVS~ was significant on univariate analysis or the adjusted logistic regression models. Table 3Logistic models for evaluating the risk of 90 days mortalityCalculate method and factorUnadjustedAdjusted by GWTGEvent/casesOR95% CI*P* valueEvent/casesOR95% CI*P* valueHigh- to low-RWT~PW~48/3372.191.15--2.190.01748/3372.261.16--4.40.017High- to low-RWT~IVS\ +\ PW~48/3371.260.68--1.260.4648/3371.190.63--2.250.6High- to low-RWT~IVS~48/3370.860.47--0.860.6448/3370.80.42--1.520.5*CI* confidence interval; *GWTG* Get With The Guideline score, *OR* odds ratio; *RWT* relative wall thickness

Receiver operating curves for 90-day mortality {#Sec20}
----------------------------------------------

A total of 48 (13%) patients died within 90 days from hospital admission. Figure [3](#Fig3){ref-type="fig"} shows the receiver operating characteristic (ROC) curves for 90-day mortality using the RWTs. The c-statistic of the ROC curve using RWT~PW~ was 62.6%, and the best cut-off value was 0.35. The c-statistic of the ROC curve using RWT~IVS + PW~ was 59.7%, and the best cut-off value was 0.55. The c-statistic of the ROC curve using RWT~IVS~ was 43.1%, and the best cut-off value was 0.36. Fig. 3Receiver operating curves for 90-day mortality using the RWTs. AUC, area under the curve

Sensitivity analysis of the survival analysis by stratified RWTs by the best cut-off {#Sec21}
------------------------------------------------------------------------------------

Additional file [1](#MOESM1){ref-type="media"}: Table S1 shows the demographic data and echocardiographic data with stratification by the best RWT cut-off. High-RWT~PW~ had worse survival than low-RWT~PW~ (*P* for log-rank test = 0.03; Additional file [2](#MOESM2){ref-type="media"}: Figure S1a). High-RWT~IVS + PW~ also had a worse prognosis than low-RWT~IVS + PW~ (*P* for log-rank test \< 0.001; Additional file [2](#MOESM2){ref-type="media"}: Figure S1b). In contrast, there was no significant difference in survival between low- and high-RWT~IVS~ (*P* for log-rank test = 0.077; Additional file [2](#MOESM2){ref-type="media"}: Figure S1c).

In the unadjusted and adjusted Cox proportional hazard models, high-RWT~PW~ and high-RWT~IVS + PW~ were associated with mortality (high-RWT~PW~, unadjusted Cox model, HR (95% CI), 1.55 (1.04--2.33), *P* = 0.033; adjusted Cox model, 1.72 (1.14--2.59), *P* = 0.01; high-RWT~IVS + PW~, unadjusted Cox model, HR (95% CI), 3.88 (2.34--6.43), *P* \<  0.001; adjusted Cox model, 3.42 (2.04--5.72), *P* \<  0.001; Additional file [3](#MOESM3){ref-type="media"}: Table S2). High-RWT~IVS~ was not a significant risk factor in the unadjusted and adjusted Cox proportional hazard models.

Relationship between RWTs and clinical characteristics {#Sec22}
------------------------------------------------------

There were significant positive correlations between the three RWTs and age and LVEF, and negative correlations between the RWTs and LogBNP and LVEDV (Table [4](#Tab4){ref-type="table"}). RWT~IVS + PW~ and RWTI~VS~ did not have significant correlations with systolic blood pressure, but RWT~PW~ did (ρ = 0.15, *P* = 0.004). Table 4Relationship between RWTs and clinical characteristicsRWT~PW~RWT~IVS + PW~RWT~IVS~ρ*P* valueρ*P* valueρ*P* valueAge, y0.150.0030.170.0030.170.001LogBNP, log (pg/mL)−0.2\<  0.001−0.150.003−0.110.039LVEF, %0.42\<  0.0010.47\<  0.0010.43\<  0.001LVEDV, mL−0.67\<  0.001−0.74\<  0.001− 0.69\<  0.001Systolic blood pressure, mmHg0.150.0040.0940.0650.0630.22*LogBNP* logarithmed brain natriuretic peptide; *LVEDV* left ventricular end-diastolic volume; *LVEF* left ventricular ejection fraction; ρ, Spearman's correlation coefficient

Reliability of TTE measurement of PWth, IVSth, and LVDd {#Sec23}
-------------------------------------------------------

Intra-observer agreement of TTE measurement of PWth was significant (ICC = 0.73, *P* \<  0.001; Fig. [4](#Fig4){ref-type="fig"}a). Inter-observer agreements of TTE measurement of PWth were also significant (observer 1 vs. 2, ICC = 0.76, *P* \<  0.001; observer 1 vs. 3, ICC = 0.6, *P* \<  0.001; observer 2 vs. 3, ICC = 0.7, *P* \<  0.001; Fig. [3](#Fig3){ref-type="fig"}a). There were no systematic biases in the intra- and inter-observer agreements in PWth measurement (Fig. [4](#Fig4){ref-type="fig"}a). Fig. 4Reliability of linear measurements of PWth, IVSth, and LVDd. IVSth, interventricular septum thickness; LVDd, left ventricular internal dimension at end-diastole; PWth, posterior wall thickness; ICC, intraclass correlation coefficient

Intra-observer agreement of TTE measurement of IVSth was significant (ICC = 0.88, *P* \<  0.001; Fig. [4](#Fig4){ref-type="fig"}b). Inter-observer agreements of TTE measurement of IVSth were also significant (observer 1 vs. 2, ICC = 0.81, *P* \<  0.001; observer 1 vs. 3, ICC = 0.77, *P* \<  0.001; observer 2 vs. 3, ICC = 0.73, *P* \<  0.001; Fig. [4](#Fig4){ref-type="fig"}b). There were no systematic biases in the intra- and inter-observer agreements in IVSth measurement (Fig. [4](#Fig4){ref-type="fig"}b).

Intra-observer agreement of TTE measurement of LVDd was significant (ICC = 0.94, *P* \<  0.001; Fig. [4](#Fig4){ref-type="fig"}c). Inter-observer agreements of TTE measurement of LVDd were also significant (observer 1 vs. 2, ICC = 0.71, *P* \<  0.001; observer 1 vs. 3, ICC = 0.92, *P* \<  0.001; observer 2 vs. 3, ICC = 0.65, *P* \<  0.001; Fig. [4](#Fig4){ref-type="fig"}c). There were no systematic biases in the intra- and inter-observer agreements in LVDd measurement (Fig. [4](#Fig4){ref-type="fig"}c).

Reliability of RWTs obtained from TTE measurement {#Sec24}
-------------------------------------------------

Intra-observer agreement of RWT~PW~ was significant (ICC = 0.77, *P* \<  0.001; Fig. [5](#Fig5){ref-type="fig"}a). Inter-observer agreements of RWT~PW~ were significant (observer 1 vs. 2, ICC = 0.74, *P* \<  0.001; observer 1 vs. 3, ICC = 0.63, *P* \<  0.001; observer 2 vs. 3, ICC = 0.8, *P* \<  0.001). There were no systematic biases in the intra- and inter-observer agreements in RWT~PW~. Fig. 5Reliability of RWTs. RWT, relative wall thickness. RWT~PW~ = 2 × PWth/LVDd, RWT~IVS + PW~ = (IVSth + PWth)/LVDd, and RWT~IVS~ = 2 × IVSth/LVDd in which PWth = posterior wall thickness, IVSth = interventricular septum thickness, and LVDd = left ventricular internal dimension at end-diastole

Intra-observer agreement of RWT~IVS + PW~ was significant (ICC = 0.89, *P* \<  0.001; Fig. [5](#Fig5){ref-type="fig"}b). Inter-observer agreements of RWT~PW~ were also significant (observer 1 vs. 2, ICC = 0.82, *P* \<  0.001; observer 1 vs. 3, ICC = 0.74, *P* \<  0.001; observer 2 vs. 3, ICC = 0.83, *P* \<  0.001). There were no systematic biases in the intra- and inter-observer agreements in RWT~IVS + PW~.

Intra-observer agreement of RWT~IVS~ was significant (ICC = 0.84, *P* \<  0.001; Fig. [5](#Fig5){ref-type="fig"}c). Inter-observer agreements of RWT~IVS~ were also significant (observer 1 vs. 2, ICC = 0.77, *P* \<  0.001; observer 1 vs. 3, ICC = 0.75, *P* \<  0.001; observer 2 vs. 3, ICC = 0.72, *P* \<  0.001). There were no systematic biases in the intra- and inter-observer agreements in RWT~IVS~.

Discussion {#Sec25}
==========

To the best of our knowledge, this is the first study to show the difference in the clinical significance of the three RWTs. The present study demonstrated that, compared to RWT~IVS + PW~ and RWT~IVS~, RWT~PW~ is the best to stratify the risk for all-cause death in ADHF patients. This may be consistently supported by three findings. First, high-RWT~PW~ had a significantly worse prognosis than low-RWT~PW~. In contrast, on survival analysis, there was no significant difference between high- and low-RWT~IVS + PW~ or RWT~IVS~. Second, in the logistic regression model for 90-day mortality, only high-RWT~PW~ was significant among the three RWTs (Table [3](#Tab3){ref-type="table"}). Third, ROC for 90-day all-cause death using RWT~PW~ had the highest c-statistic among the three ROCs.

Explanations of the differences in the prognostic values among the three RWTs {#Sec26}
-----------------------------------------------------------------------------

High-RWT~PW~ was associated with a poor prognosis on survival analysis and Cox proportional hazard models (Fig. [2](#Fig2){ref-type="fig"}a; Table [2](#Tab2){ref-type="table"}). High-RWT~IVS + PW~ was not associated with poor survival on survival analysis (Fig. [1](#Fig1){ref-type="fig"}b), whereas high-RWT~IVS + PW~ was a significant risk only in the Cox proportional hazard model adjusted by GWTG, not in the unadjusted model (Table [2](#Tab2){ref-type="table"}). High-RWT~IVS~ did not show worse survival than low-RWT~IVS~ (Fig. [1](#Fig1){ref-type="fig"}c; Table 2). The equations of RWT~PW~ and RWT~IVS + PW~ contain PWth. PWth or the ratio of PWth to LVDd, therefore, may represent the LV remodeling related to a worse prognosis better than IVSth or IVSth to LVDd in patients with ADHF. Patients with high-RWT~PW~ had higher systolic blood pressure than those with low-RWT~PW~ (Table [1](#Tab1){ref-type="table"}), while there was no such difference either between low- and high-RWT~IVS + PW~ or between low- and high-RWT~IVS~. RWT~PW~ had a positive correlation with systolic blood pressure (Table [4](#Tab4){ref-type="table"}), while either RWT~IVS + PW~ or RWT~IVS~ did not. This may suggest that thickening of PWth, rather than IVSth, is likely to counterbalance pressure overload and may lead to LV diastolic dysfunction leading to a poor prognosis. A higher A wave in high RWT~pw~ patients than in low RWT~pw~ patients may support this assumption (Table [1](#Tab1){ref-type="table"}).

In terms of methodological validity, there were no differences in inter- and intra-observer agreements for each RWT. Given that fairly good reproducibility was observed in all measurements, differences in prognostic values among the three RWTs may not result from technical aspects of TTE.

Paradoxically, high-RWT~PW~ patients had lower BNP than low-RWT~PW~ patients (Table [1](#Tab1){ref-type="table"}). High-RWT~PW~ included 101 (53%) patients with HFpEF. Generally, BNP increases modestly in HFpEF \[[@CR18]\]. Furthermore, the prognostic value of BNP has not been confirmed in patients with HFpEF \[[@CR19]\]. High RWT~PW~ might be of clinically utility, especially, in patients with HFpEF.

Limitations {#Sec27}
===========

The present study had several limitations. The present study did not have pressure data such as LV end-diastolic pressure or pulmonary artery wedge pressure. LV wall thickness was not evaluated by other modalities, such as magnetic resonance imaging or computed tomography. Patients having valvular diseases with various etiologies were included, which might affect the prognostic value of RWTs.

In conclusion, high-RWT~PW~ had a higher systolic pressure and A wave than low-RWT~PW~. This finding was not observed in the comparison between low- and high-RWT~IVS + PW~ or between low-and high-RWT~IVS~. PWth may represent pressure overload better than IVSth. When calculating RWT, RWT~PW~ should be recommended for evaluating the mortality risk in ADHF.

Supplementary information
=========================
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**Additional file 1: Table S1.** Demographic data and echocardiographic parameters. **Additional file 2: Figure S1.** Kaplan-Meier Curves for all-cause mortality stratified by the stratified RWTs by the best cut-off. **Additional file 3: Table S2.** Cox proportional hazard model for evaluate the risk of high RWTs for all-cause mortality.
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